Senior insider sale
EVP & GENERAL COUNSEL at UNITED THERAPEUTICS CORP — senior position signals high conviction
$39.06M
82.60K shares
MAHON PAUL A plans to sell 82.60K shares of UNITED THERAPEUTICS CORP valued at approximately $39.06M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Stock Option Exercise
Cash
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/15/2026 | Stock Option Exercise Cash | 8.30K | — |
| Total | 8.30K | ||
Completed
Units to sell
8.30K
Market value
$4.03M
Units to sell
11K
Market value
$5.64M
Units to sell
11K
Market value
$5.33M
Units to sell
11K
Market value
$5.35M
Units to sell
11K
Market value
$5.11M
Units to sell
11K
Market value
$4.95M
Units to sell
11K
Market value
$4.75M
Planned — Approximate Date
Units to sell
8.30K
Market value
$3.90M
Units
82.60K
Value
$39.06M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/2/2026 | 8.30K | $4.03M | — | Completed |
12/24/2025 | 11K | $5.64M | — | Completed |
12/11/2025 | 11K | $5.33M | — | Completed |
11/26/2025 | 11K | $5.35M | — | Completed |
11/13/2025 | 11K | $5.11M | — | Completed |
10/30/2025 | 11K | $4.95M | — | Completed |
10/16/2025 | 11K | $4.75M | — | Completed |
| Planned — Approximate Date | ||||
1/15/2026 | 8.30K | $3.90M | NASDAQ | Planned |
| Total | 82.60K | $39.06M | ||